Search
Filter by Topic
- (-) Remove Technologies filter Technologies
- Reproduction (29) Apply Reproduction filter
- Processes (6) Apply Processes filter
- Ethics (3) Apply Ethics filter
- Theories (3) Apply Theories filter
- Disorders (2) Apply Disorders filter
- Experiments (2) Apply Experiments filter
- Organisms (2) Apply Organisms filter
- Legal (1) Apply Legal filter
- Publications (1) Apply Publications filter
Filter by Format
The Measles, Mumps, and Rubella (MMR) Vaccine
The measles, mumps, and rubella (MMR) vaccine was created by Maurice Hilleman in 1971 at the Merck Institute of Therapeutic Research, a pharmaceutical company in West Point, Pennsylvania. It combined three separate vaccines for measles, mumps, and rubella, common and sometimes fatal diseases. Measles causes a red skin rash and severe fevers that can be fatal. Mumps causes fever and swelling of the salivary glands in the mouth and jaw, while rubella causes milder fevers and skin rashes.
Format: Articles
Subject: Technologies
The Development of Silicone Breast Implants for Use in Breast Augmentation Surgeries in the United States
In the 1960s, two plastic surgeons from the United States, Thomas Dillon Cronin and Frank Judson Gerow, collaborated with the Dow Corning Corporation, which specialized in silicone products, to create the first silicone breast implant. Surgeons used the implant, named the Cronin-Gerow implant, to improve the look of a woman’s breasts, by correcting for asymmetry, augmenting the size, or creating a more uplifted profile.
Format: Articles
Subject: Technologies, Processes
Copper Intrauterine Device (IUD)
The copper intrauterine device, or IUD, is a long-term, reversible contraceptive first introduced by Howard Tatum and Jamie Zipper in 1967. Health care providers place an IUD inside a woman’s uterus to prevent pregnancy. Copper IUDs are typically made of T-shaped plastic with some portion covered with exposed copper. Prior to the invention of the first IUDs, women had few long-term options for safe and reliable birth control. Those options mostly consisted of barrier methods and the oral birth control pill, which were only effective if used correctly and consistently.
Format: Articles
Subject: Technologies
Kangaroo Mother Care
Physician researchers Edgar Rey Sanabria and Héctor Martínez-Gómez developed the Kangaroo Mother Program in Bogotá, Colombia, in 1979, as an alternative to conventional incubator treatment for low birth weight infants. As of 2018, low birth weight and its associated complications are the leading causes of infant death, especially in developing and underdeveloped countries where access to technology and skilled healthcare providers is limited. Kangaroo Mother Care is a simple and low cost method for treating low birth weight infants.
Format: Articles
Subject: Technologies
The Infant Incubator in Europe (1860-1890)
In the nineteenth century, obstetricians in Europe began to construct devices to incubate infants in increasingly controlled environments. The infant incubator is a medical device that maintains stable conditions and a germ free environment for premature infants born before the thirty-seventh week of pregnancy. Records show that physicians had used infant incubators since 1835. However, Jean-Louis-Paul Denuce, a physician who worked in Bordeaux, France, first published about incubator technology in 1857.
Format: Articles
Subject: Technologies, Reproduction
The Dalkon Shield
The Dalkon Shield was an intrauterine contraceptive device (IUD) that women used in the early 1970s and 1980s. Produced by the A.H. Robins Company in the US, the Dalkon Shield was a contraceptive device placed directly into a woman’s uterus that was supposed to prevent the development of a fetus in the uterus. In the 1980s, researchers uncovered an array of severe birth defects and injuries caused by the Dalkon shield, including pelvic infection, infertility, and death of the user. Eventually the A.H.
Format: Articles
Subject: Technologies
Noninvasive Fetal Aneuploidy Detection for Trisomy 21, 13, and 18
Noninvasive fetal aneuploidy detection technology allows for the detection of fetal genetic conditions, specifically having three chromosomes, a condition called aneuploidy, by analyzing a simple blood sample from the pregnant woman. Dennis Lo and Rossa Chiu researched methods of detection of aneuploidies in the early twenty-first century. Their research has been specifically applied to three trisomies, trisomy twenty-one known as Down syndrome, trisomy eighteen known as Edwards Syndrome, and trisomy thirteen known as Patau Syndrome.
Format: Articles
Subject: Technologies
"Screening for Congenital Hypothyroidism" (1991), by Delbert A. Fisher
In his 1991 article Screening for Congenital Hypothyroidism, Delbert A. Fisher in the US reported on the implementation and impact of mass neonatal screening programs for congenital hypothyroidism (CH) from the early 1970s through 1991. CH is a condition that causes stunted mental and physical development in newborns unless treatment begins within the first three months of the newborn's life. In the early 1970s, regions in Canada and the US had implemented screening programs to diagnose and treat CH as quickly as possible after the infant's birth.
Format: Articles
Subject: Publications, Technologies
Hanging Drop Tissue Culture
The hanging drop tissue culture is a technique utilized in embryology and other fields to allow growth that would otherwise be restricted by the flat plane of culture dishes and also to minimize the surface area to volume ratio, slowing evaporation. The classic hanging drop culture is a small drop of liquid, such as plasma or some other media allowing tissue growth, suspended from an inverted watch glass. The hanging drop is then suspended by gravity and surface tension, rather than spreading across a plate.
Format: Articles
Subject: Technologies
Susceptibility Assay
Charles Manning Child designed an experimental test, the susceptibility assay, to measure the effects of different toxins on developmental processes. The susceptibility assay measured an organism s vulnerability to death when it was submerged in a noxious solution. The assay involved immersing an organism in a solution that contained a depressant or inhibitory substance, such as alcohol, and then measuring the responses of the organism. Child interpreted these measurements as revealing information about the relative levels of metabolic activity within the organism.
Format: Articles
Subject: Technologies
Chorionic Villus Sampling
Chorionic villus sampling (CVS) is a test used for prenatal diagnosis. Safe to perform at an earlier stage in pregnancy than amniocentesis, CVS is another invasive prenatal diagnostic test that can be performed as early as ten weeks after the woman's last menstrual cycle. While this test does carry some risks, it is generally very effective at predicting heritable diseases during or soon after the embryonic stage of development.
Format: Articles
Subject: Technologies
Plan B: Emergency Contraceptive Pill
Plan B is a progestin-only emergency contraceptive pill (ECP) that can be taken within seventy-two hours of unprotected sex in order to prevent an unwanted pregnancy. Plan B was created in response to the United States Food and Drug Administration's (US FDA) 1997 request for new drug applications (NDAs) for a dedicated ECP product, and was approved for sales in the US in 1999. Duramed, a subsidiary of Barr Pharmaceuticals, manufactures Plan B for The Women's Capital Corporation (WCC), which owns the patent for Plan B.
Format: Articles
Subject: Technologies, Reproduction
Enovid: The First Hormonal Birth Control Pill
Enovid was the first hormonal birth control pill. G. D. Searle and Company began marketing Enovid as a contraceptive in 1960. The technology was created by the joint efforts of many individuals and organizations, including Margaret Sanger, Katharine McCormick, Gregory Pincus, John Rock, Syntex, S.A. Laboratories, and G.D. Searle and Company Laboratories.
Format: Articles
Subject: Technologies, Reproduction
Progestin: Synthetic Progesterone
Progestin is a synthetic form of progesterone, a naturally occurring hormone, which plays an important role in the female reproductive cycle. During the 1950s two types of progestin that were later used in birth control pills were created, norethindrone and norethynodrel. In 1951 Carl Djerassi developed norethindrone at Syntex, S.A. laboratories located in Mexico City, receiving a patent on 1 May 1956. In 1953 Frank Colton developed norethynodrel at G.D. Searle and Company laboratories located in Chicago, receiving a patent on 29 November 1955.
Format: Articles
Subject: Technologies, Reproduction
James Marion Sims's Treatment of Vesico-Vaginal Fistula
James Marion Sims developed a treatment for vesico-vaginal fistulas in Montgomery, Alabama in the 1840s. Vesico-vaginal fistulas were a relatively common condition in which a woman's urine leaked into her vaginal cavity from her bladder, and many regarded the fistulas as untreatable during the early 1800s. After years of efforts to repair the fistulas with myriad tools, techniques, and procedures, Sims developed the speculum and a vaginal examination position later named for him.
Format: Articles
Subject: Technologies, Reproduction
The Game of Life, by John Horton Conway
The Game of Life, or just Life, is a one-person game that was created by the English mathematician John Horton Conway in the late 1960s. It is a simple representation of birth, death, development, and evolution in a population of living organisms, such as bacteria. Martin Gardner popularized the Game of Life by writing two articles for his column "Mathematical Games" in the journal Scientific American in 1970 and 1971. There exist several websites that provide the Game of Life as a download or as an online game.
Format: Articles
Subject: Technologies
Amniocentesis
Amniocentesis is a test used for prenatal diagnosis of inherited diseases, Rh incompatibility, neural tube defects, and lung maturity. Normally performed during the second trimester of a pregnancy, this invasive procedure allows the detection of health problems in the fetus as early as fifteen weeks gestation. Although amniocentesis does carry some significant risks, the medical community commonly accepts it as a safe and useful procedure.
Format: Articles
Subject: Technologies, Reproduction
Hormone Releasing Intrauterine Devices
Hormone releasing intrauterine devices or hormonal IUDs are contraceptive devices placed in a woman’s uterus to prevent pregnancy by continuously releasing a low dose of certain hormones. Jouri Valter Tapani Luukkainen, a medical researcher at the University of Helsinki, introduced the first hormonal IUD in 1976. Luukkainen’s IUD was a plastic device shaped like a capital T.
Format: Articles
Subject: Technologies
Menstrual Tampon
Menstrual tampons are feminine hygiene devices, usually made of absorbent cotton, that are temporarily inserted into the vagina for absorbing a woman’s blood during menstruation. In 1931, Earl Haas invented the menstrual tampon most commonly used in the twenty-first century. Later, Gertrude Tendrich produced the first commercial tampon brand, Tampax, using Haas’s patented design. Tendrich and Haas’s tampon was made of tightly compacted absorbent cotton, shaped like a bullet, and had a string attached at the base that allowed for easy removal from the woman’s body.
Format: Articles
Subject: Technologies
Jelly Fish and Green Fluorescent Protein
The crystal jellyfish, Aequorea victoria, produces and emits light, called bioluminescence. Its DNA codes for sequence of 238 amino acids that forms a protein called Green Fluorescent Protein (GFP). FP is folded so that a part of the protein, called the chromophore, is located in the center of the protein. The chemical structure of the chromophore emits a green fluorescence when exposed to light in the range of blue to ultraviolet.
Format: Graphics
Subject: Theories, Processes, Organisms, Technologies
Beadle and Ephrussi’s Technique to Transplant Optic Discs between Fruit Fly Larvae
In 1935, George Beadle and Boris Ephrussi developed a technique to transplant optic discs between fruit fly larvae. They developed it while at the California Institute of Technology in Pasedena, California. Optic discs are tissues from which the adult eyes develop. Beadle and Ephrussi used their technique to study the development of the eye and eye pigment. (1) The experimenter dissects a donor larva, which is in the third instar stage of development, and removes the optic disc (colored red) with a micropipette.
Format: Graphics
Subject: Technologies, Experiments, Organisms
The Ponseti Method to Treat Club Foot
Ignacio Vives Ponseti developed a noninvasive method for treating congenital club foot in the US during the late 1940s. Congenital club foot is a birth deformity in which one or both of an infant's feet are rotated inward beneath the ankle, making normal movement rigid and painful. Ponseti developed a treatment method, later called the Ponseti method, that consisted of a series of manipulations and castings of the club foot performed in the first few months of life.
Format: Articles
Subject: Technologies
Light Therapy for Neonatal Jaundice
Light therapy, also called phototherapy, exposes infants with jaundice, a yellowing of the skin and eyes, to artificial or natural light to break down the buildup of bilirubin pigment in the blood. Bilirubin is an orange to red pigment produced when red blood cells break down, which causes infants to turn into a yellowish color. Small amounts of bilirubin in the blood are normal, but when there is an accumulation of excess bilirubin pigment, the body deposits the excess bilirubin in the layer of fat beneath the skin.
Format: Articles
Subject: Technologies
The Apgar Score (1953-1958)
In 1952 Virginia Apgar, a physician at the Sloane Women’s Hospital in New York City, New York, created the Apgar score as a method of evaluating newborn infants’ health to determine if they required medical intervention. The score included five separate categories, including heart rate, breathing rate, reaction to stimuli, muscle activity, and color. An infant received a score from zero to two in each category, and those scores added up to the infant’s total score out of ten. An infant with a score of ten was healthy, and those with low scores required medical attention at birth.
Format: Articles
Subject: Technologies, Processes
Golgi Staining Technique
The Golgi staining technique, also called the black reaction after the stain's color, was developed in the 1870s and 1880s in Italy to make brain cells (neurons) visible under the microscope. Camillo Golgi developed the technique while working with nervous tissue, which required Golgi to examine cell structure under the microscope. Golgi improved upon existing methods of staining, enabling scientists to view entire neurons for the first time and changing the way people discussed the development and composition of the brain's cells.
Format: Articles
Subject: Technologies, Processes